Literature DB >> 23708003

Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming.

Xiaopeng Liu1, Hao Sun, Jing Qi, Linli Wang, Songwei He, Jing Liu, Chengqian Feng, Chunlan Chen, Wen Li, Yunqian Guo, Dajiang Qin, Guangjin Pan, Jiekai Chen, Duanqing Pei, Hui Zheng.   

Abstract

Present practices for reprogramming somatic cells to induced pluripotent stem cells involve simultaneous introduction of reprogramming factors. Here we report that a sequential introduction protocol (Oct4-Klf4 first, then c-Myc and finally Sox2) outperforms the simultaneous one. Surprisingly, the sequential protocol activates an early epithelial-to-mesenchymal transition (EMT) as indicated by the upregulation of Slug and N-cadherin followed by a delayed mesenchymal-to-epithelial transition (MET). An early EMT induced by 1.5-day TGF-β treatment enhances reprogramming with the simultaneous protocol, whereas 12-day treatment blocks reprogramming. Consistent results were obtained when the TGF-β antagonist Repsox was applied in the sequential protocol. These results reveal a time-sensitive role of individual factors for optimal reprogramming and a sequential EMT-MET mechanism at the start of reprogramming. Our studies provide a rationale for further optimizing reprogramming, and introduce the concept of a sequential EMT-MET mechanism for cell fate decision that should be investigated further in other systems, both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23708003     DOI: 10.1038/ncb2765

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  50 in total

Review 1.  Mechanisms and functional implications of adult neurogenesis.

Authors:  Chunmei Zhao; Wei Deng; Fred H Gage
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

2.  H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs.

Authors:  Jiekai Chen; He Liu; Jing Liu; Jing Qi; Bei Wei; Jiaqi Yang; Hanquan Liang; You Chen; Jing Chen; Yaran Wu; Lin Guo; Jieying Zhu; Xiangjie Zhao; Tianran Peng; Yixin Zhang; Shen Chen; Xuejia Li; Dongwei Li; Tao Wang; Duanqing Pei
Journal:  Nat Genet       Date:  2012-12-02       Impact factor: 38.330

3.  Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression.

Authors:  Linzhao Cheng; Nancy F Hansen; Ling Zhao; Yutao Du; Chunlin Zou; Frank X Donovan; Bin-Kuan Chou; Guangyu Zhou; Shijie Li; Sarah N Dowey; Zhaohui Ye; Settara C Chandrasekharappa; Huanming Yang; James C Mullikin; P Paul Liu
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

4.  Immunogenicity of induced pluripotent stem cells.

Authors:  Tongbiao Zhao; Zhen-Ning Zhang; Zhili Rong; Yang Xu
Journal:  Nature       Date:  2011-05-13       Impact factor: 49.962

5.  Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells.

Authors:  Julia Schulte; Michaela Weidig; Philipp Balzer; Petra Richter; Marcus Franz; Kerstin Junker; Mieczyslaw Gajda; Karlheinz Friedrich; Heiko Wunderlich; Arne Östman; Iver Petersen; Alexander Berndt
Journal:  Histochem Cell Biol       Date:  2012-07-22       Impact factor: 4.304

6.  Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

Authors:  Shih-Hwa Chiou; Mong-Lien Wang; Yu-Ting Chou; Chi-Jen Chen; Chun-Fu Hong; Wang-Ju Hsieh; Hsin-Tzu Chang; Ying-Shan Chen; Tzu-Wei Lin; Han-Sui Hsu; Cheng-Wen Wu
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

7.  Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells.

Authors:  Margaret A Young; David E Larson; Chiao-Wang Sun; Daniel R George; Li Ding; Christopher A Miller; Ling Lin; Kevin M Pawlik; Ken Chen; Xian Fan; Heather Schmidt; Joelle Kalicki-Veizer; Lisa L Cook; Gary W Swift; Ryan T Demeter; Michael C Wendl; Mark S Sands; Elaine R Mardis; Richard K Wilson; Tim M Townes; Timothy J Ley
Journal:  Cell Stem Cell       Date:  2012-04-26       Impact factor: 24.633

Review 8.  Transitions between epithelial and mesenchymal states in development and disease.

Authors:  Buzz Baum; Jeffrey Settleman; Margaret P Quinlan
Journal:  Semin Cell Dev Biol       Date:  2008-02-09       Impact factor: 7.727

9.  Evidence for mesenchymal-epithelial transition associated with mouse hepatic stem cell differentiation.

Authors:  Bin Li; Yun-Wen Zheng; Yuuki Sano; Hideki Taniguchi
Journal:  PLoS One       Date:  2011-02-11       Impact factor: 3.240

10.  Direct cell reprogramming is a stochastic process amenable to acceleration.

Authors:  Jacob Hanna; Krishanu Saha; Bernardo Pando; Jeroen van Zon; Christopher J Lengner; Menno P Creyghton; Alexander van Oudenaarden; Rudolf Jaenisch
Journal:  Nature       Date:  2009-11-08       Impact factor: 49.962

View more
  93 in total

Review 1.  The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance.

Authors:  Jonathan H Teichroeb; Joohwan Kim; Dean H Betts
Journal:  RNA Biol       Date:  2016-01-19       Impact factor: 4.652

Review 2.  Toward pluripotency by reprogramming: mechanisms and application.

Authors:  Tao Wang; Stephen T Warren; Peng Jin
Journal:  Protein Cell       Date:  2013-11       Impact factor: 14.870

3.  Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy.

Authors:  M Swiderska-Syn; W K Syn; G Xie; L Krüger; M V Machado; G Karaca; G A Michelotti; S S Choi; R T Premont; A M Diehl
Journal:  Gut       Date:  2013-10-30       Impact factor: 23.059

4.  Autophagy and mTORC1 regulate the stochastic phase of somatic cell reprogramming.

Authors:  Yasong Wu; Yuan Li; Hui Zhang; Yinghua Huang; Ping Zhao; Yujia Tang; Xiaohui Qiu; Yue Ying; Wen Li; Su Ni; Meng Zhang; Longqi Liu; Yan Xu; Qiang Zhuang; Zhiwei Luo; Christina Benda; Hong Song; Baohua Liu; Liangxue Lai; Xingguo Liu; Hung-Fat Tse; Xichen Bao; Wai-Yee Chan; Miguel A Esteban; Baoming Qin; Duanqing Pei
Journal:  Nat Cell Biol       Date:  2015-05-18       Impact factor: 28.824

Review 5.  Cell signalling pathways underlying induced pluripotent stem cell reprogramming.

Authors:  Kate Hawkins; Shona Joy; Tristan McKay
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

Review 6.  Application of biomaterials to advance induced pluripotent stem cell research and therapy.

Authors:  Zhixiang Tong; Aniruddh Solanki; Allison Hamilos; Oren Levy; Kendall Wen; Xiaolei Yin; Jeffrey M Karp
Journal:  EMBO J       Date:  2015-03-12       Impact factor: 11.598

Review 7.  Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.

Authors:  E-Jean Tan; Anna-Karin Olsson; Aristidis Moustakas
Journal:  Cell Adh Migr       Date:  2014-11-17       Impact factor: 3.405

8.  Novel mouse model recapitulates genome and transcriptome alterations in human colorectal carcinomas.

Authors:  Nicole E McNeil; Hesed M Padilla-Nash; Floryne O Buishand; Yue Hue; Thomas Ried
Journal:  Genes Chromosomes Cancer       Date:  2016-11-01       Impact factor: 5.006

9.  miRNAs promote generation of porcine-induced pluripotent stem cells.

Authors:  Kuiying Ma; Guangqi Song; Xinglan An; Anran Fan; Wentao Tan; Bo Tang; Xueming Zhang; Ziyi Li
Journal:  Mol Cell Biochem       Date:  2014-01-24       Impact factor: 3.396

10.  AP-1 activity is a major barrier of human somatic cell reprogramming.

Authors:  Yuting Liu; Jiangping He; Ruhai Chen; He Liu; Jocelyn Chen; Yujian Liu; Bo Wang; Lin Guo; Duanqing Pei; Jie Wang; Jing Liu; Jiekai Chen
Journal:  Cell Mol Life Sci       Date:  2021-06-28       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.